Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference Nov 27, 2017 04:10PM
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference Nov 21, 2017 04:10PM
Sucampo to Host 2017 R&D Day on November 16 in New York Nov 9, 2017 05:48PM
Sucampo Reports Third Quarter 2017 Financial Results Nov 1, 2017 06:30AM
Sucampo Announces Third Quarter 2017 Earnings Call Oct 23, 2017 04:05PM
View Older Stories

Sep 28, 2017 05:37PM Sucampo (SCMP) Reports FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation
Sep 28, 2017 05:35PM Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation
Sep 27, 2017 08:43PM Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference
Sep 21, 2017 08:25AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
Sep 20, 2017 04:15PM Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel
Sep 19, 2017 04:15PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference
Sep 11, 2017 08:32AM UPDATE: Cancer Prevention Pharmaceuticals Secures $9.5M in Additional Funding from Sucampo (SCMP) Following Phase 3 Trial Progress
Sep 11, 2017 08:30AM Cancer Prevention Pharmaceuticals Receives $9.5 Million in Additional Funding from Sucampo Following Phase 3 Trial Progress
Aug 30, 2017 04:05PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Wells Fargo Healthcare Conference
Aug 2, 2017 06:30AM Sucampo Reports Second Quarter 2017 Financial Results
Jul 19, 2017 04:05PM Sucampo Announces Second Quarter 2017 Earnings Call
Jul 18, 2017 04:06PM Sucampo Pharma (SCMP) Names Karen Smith to Board of Directors
Jul 18, 2017 04:05PM Dr. Karen Smith Joins Sucampo’s Board of Directors
Jun 13, 2017 04:33PM Sucampo Pharma (SCMP) Receives New Patent for VTS-270
Jun 13, 2017 04:30PM Sucampo Pharmaceuticals Announces Issuance of New Patent for VTS-270
Jun 1, 2017 04:30PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2017 Global Healthcare Conference
May 11, 2017 04:05PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2017 Health Care Conference
May 3, 2017 06:30AM Sucampo Reports First Quarter 2017 Financial Results
Apr 26, 2017 04:01PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Deutsche Bank 42nd Annual Health Care Conference
Apr 19, 2017 06:30AM Sucampo Announces First Quarter 2017 Earnings Call
Apr 18, 2017 06:34AM Sucampo Pharma (SCMP) Confirms New Study Published in PLOS ONE Advances Science on VTS-270 for Treatment of Niemann-Pick Disease Type C1
Apr 18, 2017 06:30AM New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1
Apr 3, 2017 06:31AM Sucampo Pharma (SCMP) to Acquire Vtesse for $200M
Apr 3, 2017 06:30AM Sucampo Acquires Vtesse Inc.
Mar 28, 2017 04:01PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Annual Needham Healthcare Conference
Mar 15, 2017 05:01PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference
Mar 8, 2017 06:30AM Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 23, 2017 04:02PM Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call
Feb 9, 2017 06:30AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference
Nov 9, 2016 06:30AM Sucampo Reports Third Quarter 2016 Financial Results
Oct 28, 2016 06:30AM Sucampo Announces Third Quarter 2016 Earnings Call
Aug 3, 2016 06:30AM Sucampo Reports Second Quarter 2016 Financial Results
Jul 29, 2016 06:30AM Paul Edick Joins Sucampo’s Board of Directors
Jul 20, 2016 06:45AM Sucampo Announces Second Quarter 2016 Earnings Call
Jul 11, 2016 07:32AM Sucampo Pharma (SCMP) to Discontinue Cobiprostone Development Following Phase 2a Results
Jul 11, 2016 07:30AM Sucampo Provides Update on Cobiprostone Development Program
Jul 8, 2016 04:02PM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
May 31, 2016 06:45AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2016 Healthcare Conference
May 17, 2016 06:45AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 UBS Global Healthcare Conference
May 4, 2016 06:30AM Sucampo Reports Strong Results for First Quarter of 2016
May 3, 2016 06:45AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2016 Healthcare Conference
Apr 28, 2016 07:03AM Newest Release of Veeva Vault Streamlines Global Business Processes to Get Products to Market Faster and More Efficiently
Apr 28, 2016 07:03AM Sucampo Standardizes on Veeva Vault for a Single Source of Truth Enterprise-wide
Apr 28, 2016 07:03AM CORRECTING and REPLACING Sucampo Standardizes on Veeva Vault for a Single Source of Truth and Enterprise-wide Capability
Apr 20, 2016 06:45AM Sucampo Announces First Quarter 2016 Earnings Call
Apr 19, 2016 07:02AM Sucampo Pharma (SCMP) Phase 2a Study of Cobiprostone Missed Primary Endpoints
Apr 19, 2016 07:00AM Sucampo Reports Top-Line Data from Phase 2a Study of Cobiprostone in Patients with PPI-Refractory Non-Erosive Reflux Disease (NERD) and Symptomatic Gastroesophageal Reflux Disease (sGERD)
Mar 9, 2016 06:45AM Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Annual ROTH Conference
Mar 8, 2016 06:30AM Sucampo Reports Continued Strong Performance for Fourth Quarter and Full Year 2015
Feb 23, 2016 06:45AM Sucampo Announces Fourth Quarter and Full Year 2015 Earnings Call
View Older Stories